Post-marketing safety of anakinra and canakinumab: a real-world pharmacovigilance study based on FDA adverse event reporting system. [PDF]
Liu H, Yan W, Li J, Yan D, Luo D.
europepmc +1 more source
The role of immunotherapy in a refractory case of acute hemorrhagic leukoencephalitis in a pediatric patient. [PDF]
Johnson R, Khan MB.
europepmc +1 more source
Effective Treatment of Macrophage Activation Syndrome Linked to Systemic Lupus Erythematosus Using Interleukin-1 Inhibitor. [PDF]
Barlas N+4 more
europepmc +1 more source
Background Novel host-directed therapies are urgently needed for patients with dengue, particularly those at high risk of developing severe disease.
Angela McBride+19 more
doaj
Interleukin-1-receptor antagonist in the Muckle-Wells syndrome [PDF]
Hawkins, PN, Lachmann, HJ, McDermott, MF
core +1 more source
Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis. [PDF]
Wang K+5 more
europepmc +1 more source
A case with systemic juvenile idiopathic arthritis treated with tofacitinib and rapamycin. [PDF]
Cam V, Sag E, Bilginer Y, Ozen S.
europepmc +1 more source
Advancing multidisciplinary management of pediatric hyperinflammatory disorders. [PDF]
La Torre F+9 more
europepmc +1 more source
Unmet needs and research gaps in Still's disease across ages: proceedings from a pediatric and adult joint expert panel. [PDF]
Bracaglia C+6 more
europepmc +1 more source